ESSA Pharma (EPIX) Stock Statistics & Valuation Metrics

ESSA Pharma has a market cap or net worth of $75.90M. The enterprise value is -$9.96M.

ESSA Pharma has 44,388,550 shares outstanding. The number of shares has decreased by -2.65% in one year.

ESSA Pharma’s return on equity (ROE) is -0.22 and return on invested capital (ROIC) is -27.55%.

The current PE Ratio of ESSA Pharma is -9.40. ESSA Pharma’s PEG ratio is -0.40.

In the last 12 months, ESSA Pharma had revenue of 0.00 and earned -28.54M in profits. Earnings per share was -0.64.

In the last 12 months, operating cash flow was -22.47M and capital expenditures 0.00, giving a free cash flow of -22.47M billion.

ESSA Pharma pays an annual dividend of ―, resulting in a dividend yield of ―

ESSA Pharma upcoming earnings date is Aug 6, 2025, TBA Not Confirmed.

ESSA Pharma as a current ratio of 38.64, with Debt / Equity ratio of 0.00%

In the past 12 months, ESSA Pharma has paid 0.00 in taxes.

ESSA Pharma EV to EBITDA ratio is -5.80, with an EV/FCF ratio of -7.26.

ESSA Pharma has $120.55M in cash and marketable securities with $305.04K in debt, giving a net cash position of -$120.25M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for ESSA Pharma is $2.25, which is 11.43% higher than the current price. The consensus rating is Hold